Skip to main content
Fig. 1 | BMC Medical Imaging

Fig. 1

From: Can the apparent transverse relaxation rate (R2*) evaluate the efficacy of concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma? a preliminary experience

Fig. 1

A young man with nasopharyngeal carcinoma (AJCC stage III). (a) Axial enhanced fat suppression T1WI before CCRT with lesions located on the right side. (b) Axial enhanced fat suppression T1WI at 3 months after the end of CCRT indicates stable disease (SD) according to RECIST 1.1; the patient was included in NRG. (c) R2* value in the ROI was 36.40 Hz on the R2* color-coded map before CCRT. (d) R2* value in the ROI was 34.70 Hz at 3 months after the end of CCRT. CCRT, concurrent chemoradiotherapy; RECIST, response evaluation criteria for solid tumors; NRG, nonresponding group; ROI, region of interest’ AJCC, American Joint Committee on Cancer; T1WI, T1-weighted image

Back to article page

BMC Medical Imaging

ISSN: 1471-2342

Contact us